Evidence map›Paper›PMID 35288644›Full record

ArticleMucosal immunology2022

Microbial regulation of intestinal motility provides resistance against helminth infection.

Mati Moyat, Luc Lebon, Olaf Perdijk, Lakshanie C Wickramasinghe, Mario M Zaiss, Ilaria Mosconi, Beatrice Volpe, Nadine Guenat, Kathleen Shah, Gillian Coakley and 2 more

Open access · hybridAbstract read
In one paragraph

Article in Mucosal immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 31 citations in OpenAlex.

  1. Virulence · 2026
    Article
  2. Article
  3. Building and regenerating intestines by manipulating intestinal stem cells.Nature reviews. Gastroenterology & hepatology · 2026
    Review
  4. Observational
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Review
  16. Article
  17. Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 3 countries.

Mati Moyat *Global Health Institute, Swiss Federal Institute of Technology (EPFL), Lausanne, 1015, Lausanne, Switzerland.
Luc Lebon *Global Health Institute, Swiss Federal Institute of Technology (EPFL), Lausanne, 1015, Lausanne, Switzerland.
Olaf PerdijkDepartment of Immunology and Pathology, Central Clinical School, Monash University, The Alfred Centre, Melbourne, VIC, Australia.
Lakshanie C WickramasingheDepartment of Immunology and Pathology, Central Clinical School, Monash University, The Alfred Centre, Melbourne, VIC, Australia.
Mario M ZaissGlobal Health Institute, Swiss Federal Institute of Technology (EPFL), Lausanne, 1015, Lausanne, Switzerland.
Ilaria MosconiGlobal Health Institute, Swiss Federal Institute of Technology (EPFL), Lausanne, 1015, Lausanne, Switzerland.
Beatrice VolpeGlobal Health Institute, Swiss Federal Institute of Technology (EPFL), Lausanne, 1015, Lausanne, Switzerland.
Nadine GuenatGlobal Health Institute, Swiss Federal Institute of Technology (EPFL), Lausanne, 1015, Lausanne, Switzerland.
Kathleen ShahGlobal Health Institute, Swiss Federal Institute of Technology (EPFL), Lausanne, 1015, Lausanne, Switzerland.
Gillian CoakleyDepartment of Immunology and Pathology, Central Clinical School, Monash University, The Alfred Centre, Melbourne, VIC, Australia.
Tiffany BoucheryGlobal Health Institute, Swiss Federal Institute of Technology (EPFL), Lausanne, 1015, Lausanne, Switzerland.
Nicola L HarrisGlobal Health Institute, Swiss Federal Institute of Technology (EPFL), Lausanne, 1015, Lausanne, Switzerland. Nicola.harris@monash.edu.
École Polytechnique Fédérale de Lausanne · CHMonash University · AUThe Alfred Hospital · AUFriedrich-Alexander-Universität Erlangen-Nürnberg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Soil-transmitted helminths cause widespread disease, infecting ~1.5 billion people living within poverty-stricken regions of tropical and subtropical countries. As adult worms inhabit the intestine alongside bacterial communities, we determined whether the bacterial microbiota impacted on host resistance against intestinal helminth infection. We infected germ-free, antibiotic-treated and specific pathogen-free mice, with the intestinal helminth Heligmosomoides polygyrus bakeri. Mice harboured increased parasite numbers in the absence of a bacterial microbiota, despite mounting a robust helminth-induced type 2 immune response. Alterations to parasite behaviour could already be observed at early time points following infection, including more proximal distribution of infective larvae along the intestinal tract and increased migration in a Baermann assay. Mice lacking a complex bacterial microbiota exhibited reduced levels of intestinal acetylcholine, a major excitatory intestinal neurotransmitter that promotes intestinal transit by activating muscarinic receptors. Both intestinal motility and host resistance against larval infection were restored by treatment with the muscarinic agonist bethanechol. These data provide evidence that a complex bacterial microbiota provides the host with resistance against intestinal helminths via its ability to regulate intestinal motility.

Indexed as

HelminthiasisIntestinal Diseases, ParasiticNematospiroides dubiusStrongylida InfectionsAnimalsGastrointestinal MotilityMice

Identifiers

PMID35288644
PMCPMC9705251
OpenAlexW4221097353

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.